Invitrogen, ViroPharma each raise $150 million

Research kit company IVGN raised $150 million in convertible subordinated notes, with a $22.5 million overallotment option. The notes bear 5.5 percent interest, mature in 2007 and convert into IVGN stock at $85.20 per share. IVGN closed Friday at $79.625. ...